Why plateaus happen
- Metabolic adaptation — resting energy expenditure decreases as weight drops.
- Dose ceiling — the maximum tolerated dose has been reached.
- Behavioral drift — small caloric increases as appetite normalizes.
- Disease progression — beta-cell decline continues in type 2 diabetes.
What physicians consider first
- Confirming dose optimization and adherence
- Adding structured nutrition and resistance training to protect lean mass
- Adjusting or combining agents
- Ruling out other contributors (sleep apnea, thyroid, medications that cause weight gain)
When metabolic surgery enters the conversation
For patients who meet criteria and have plateaued despite optimized therapy, metabolic surgery is one option to discuss. It is studied as a more durable intervention because its anatomical and hormonal changes persist after treatment — unlike pharmacotherapy, which is reversed on discontinuation.
Do not stop your medication on your own
Any change in GLP-1 or GIP/GLP-1 therapy should be made with the prescribing physician. See Diabetes After GLP-1.
Ready for an individualized evaluation?
A physician evaluation is the only way to determine candidacy. Outcomes vary; no result is guaranteed.